Literature DB >> 31401578

Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington's disease.

Hesitha Abeysundera1, Allan Campbell2, Shanthi Sarma1.   

Abstract

This paper describes a patient who presented with treatment-resistant depression with comorbid anxiety symptoms in the context of Huntington's disease (HD) and developed worsening movement disorder symptoms after commencing electroconvulsive therapy (ECT) for depression. The aim of this case report is to provide medical practitioners with a greater awareness of the possibility of worsening movement disorders when using ECT for depression in a patient with HD. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  genetic screening / counselling; genetics; movement disorders (other than parkinsons); neurology (drugs and medicines); psychiatry (drugs and medicines)

Mesh:

Year:  2019        PMID: 31401578      PMCID: PMC6700561          DOI: 10.1136/bcr-2019-230389

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Huntington's disease: phenomenological diversity of a neuropsychiatric condition that challenges traditional concepts in neurology and psychiatry.

Authors:  Heike Tost; Cornelia S Wendt; Andrea Schmitt; Andreas Heinz; Dieter F Braus
Journal:  Am J Psychiatry       Date:  2004-01       Impact factor: 18.112

Review 2.  An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system.

Authors:  Bradley V Watts; Alicia Groft; James P Bagian; Peter D Mills
Journal:  J ECT       Date:  2011-06       Impact factor: 3.635

3.  Differential Response to ECT of Psychotic and Affective Symptoms in Huntington's Disease: A Case Report.

Authors:  Anne-Cécile Petit; Franz Hozer; Katia Youssov; Pierre Lavaud; Patrick Hardy; Fayçal Mouaffak
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2016       Impact factor: 2.198

4.  ECT for the treatment of Huntington's disease: a case study.

Authors:  M D Beale; C H Kellner; P Gurecki; J T Pritchett
Journal:  Convuls Ther       Date:  1997-06

5.  Lithium Treatment in Patients With Huntington's Disease and Suicidal Behavior.

Authors:  Michele Raja; Francesco Soleti; Anna Rita Bentivoglio
Journal:  Mov Disord       Date:  2015-07-24       Impact factor: 10.338

Review 6.  The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis.

Authors:  N Tørring; S N Sanghani; G Petrides; C H Kellner; S D Østergaard
Journal:  Acta Psychiatr Scand       Date:  2017-03-23       Impact factor: 6.392

7.  Treatment of Agitation in Huntington's Disease With Electroconvulsive Therapy.

Authors:  Rohit Praful Shah; Vinod Alluri; Sarita Sharma
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2017-01-25       Impact factor: 2.198

8.  ECT as a treatment for depression in Huntington's disease.

Authors:  N G Ranen; C E Peyser; S E Folstein
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1994       Impact factor: 2.198

9.  [Electroconvulsive therapy in patients with Huntington's disease and depression].

Authors:  E van Duijn; R A C Roos; L J C A Smarius; R C van der Mast
Journal:  Ned Tijdschr Geneeskd       Date:  2005-09-24

Review 10.  Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

View more
  2 in total

Review 1.  Electroconvulsive Therapy and Movement Disorders. New Perspectives on A Time-Tested Therapy.

Authors:  Pedro J Garcia Ruiz
Journal:  Mov Disord Clin Pract       Date:  2021-03-09

Review 2.  Management of Agitation in Huntington's Disease: A Review of the Literature.

Authors:  Garrett Rossi; Joan C Oh
Journal:  Cureus       Date:  2020-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.